Home/ Stocks/ BFRI

Biofrontera Inc. Common Stock

BFRI XNAS

$1.15 +0.02 (+1.75%) ▲ 15-min delayed

Open

$1.15

High

$1.16

Low

$1.12

Volume

110.3K

Market Cap

$13.81M

About Biofrontera Inc. Common Stock

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 94 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$41.70M	$-10,536,000	$-1.04
FY 2025	$41.70M	$-10,536,000	$-1.04
Q3 2025	$6.99M	$-6,649,000	$-0.62
Q1 2025	$8.59M	$-4,203,000	$-0.47

Related Market News

No specific coverage for BFRI yet. Check out our latest market news or earnings calendar.

Get BFRI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Biofrontera Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.